Takeda Pharmaceutical Company's total assets for Q2 2024 were ¥14.57T, a decrease of -10.20% from the previous quarter. TAK total liabilities were ¥7.65T for the fiscal quarter, a -9.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.